California Healthcare Transactions to Undergo Additional Advance Regulatory Scrutiny as New Office of Health Care Affordability Scrutinizes Cost and Market Impact of Transaction – JD Supra

Certain healthcare transactions closing on or after April 1, 2024 are subject to an advance notice regulatory review and analysis by a newly created Office of Health Care Affordability (“OHCA”) within the California Department of Health Care Access and Information. The OHCA will prospectively analyze the transactions by conducting a cost and market review of significant transactions and report to the public on the anticipated impacts on the healthcare market. The information submitted to the OHCA by the parties to the transaction will become public information.
These new requirements for healthcare transactions are a part of a larger budget trailer bill that strives to develop a comprehensive understanding of California healthcare cost trends and drivers of spending and also strategies for controlling costs. The trailer bill also endeavors to maintain quality and equity of healthcare.[1] In connection with these efforts, there shall be a new Health Care Affordability Board that will establish an overall healthcare cost growth target in California for changes in per capital spending. The Board will be able to set spending targets by healthcare sectors.
OHCA will monitor cost trends, including the impact of consolidation, market power, venture capital activity, profit margins and other market failures on competition, prices, access, quality and equity. If OHCA determines that the transaction is likely to have a significant effect on the California healthcare market, it will seek input from the parties and the public. Transactions that will undergo a cost and market impact review are those that the OHCA finds are likely to have a risk of a significant impact on market competition, the state’s ability to meet cost targets, or costs for purchasers and consumers.[2]
Parties to healthcare transactions must provide the notice at least 90 days in advance of closing.
This new regulatory process will be required for healthcare transactions involving healthcare payors, providers and integrated delivery systems. Healthcare providers whose transactions will be subject to the new requirement include the following:
The following transactions are subject to this advance review process:
The following transactions are exempt from the new requirements: those that are currently subject to review by the Department of Managed Healthcare, the Insurance Commissioner, the Attorney General and agreements where a California county is acquiring a healthcare provider to ensure continued access to services.
[1] See Department of Health Care Access and Information Fact Sheet available at: Office of Health Care Affordability Fact Sheet.
[2] Chapter 47, Senate Bill 184, Enrolled June 30, 2022, see new California Health & Safety Code Section 125706 et seq. effective January 1, 2023.
See more »
DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.
© Weintraub Tobin | Attorney Advertising
Refine your interests »
This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.
Back to Top
Explore 2022 Readers’ Choice Awards
Copyright © JD Supra, LLC

source

Leave a Comment

Ads Blocker Image Powered by Code Help Pro

Ads Blocker Detected!!!

Welcome to FactsPrime

Sorry, We have detected that you have activated Ad-Blocker. Please Consider supporting us by disabling your Ad Blocker, It helps us in maintaining this website. To View the content, Please disable adblocker and refresh the page.

Thank You !!!